Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
62,915,975
Share change
-61,349
Total reported value
$1,512,522,250
Put/Call ratio
27%
Price per share
$24.02
Number of holders
176
Value change
-$90,036,678
Number of buys
101
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q1 2025

As of 31 Mar 2025, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 176 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,915,975 shares. The largest 10 holders included Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, Sofinnova Investments, Inc., COMMODORE CAPITAL LP, Vestal Point Capital, LP, Kynam Capital Management, LP, and Holocene Advisors, LP. This page lists 176 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.